A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants
Clinical trial NCT05338489 · COMPLETED
Trial details
- NCT number
- NCT05338489
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-11
- Primary completion
- 2018-07-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.